Correction: Molecular profile of BRCA-mutated biliary tract cancers

Detalles Bibliográficos
Main Authors:	Matthias Preusser, Hannah Christina Puhr, Anna Sophie Berghoff, Thorsten Fuereder, Florian Moik, Gerwin Heller, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, Julia Maria Berger, Judith Kreminger, Lorenz Schubert, Angelika Martina Starzer, Ariane Steindl, Stefan Winkler, Selma Tobudic
Formato:	Artigo
Idioma:	English
Publicado:	Elsevier 2020-10-01
Series:	ESMO Open
Acceso en liña:	https://esmoopen.bmj.com/content/5/5/e000682corr1.full

Títulos similares

SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic
por: Matthias Preusser, et al.
Publicado: (2020-10-01)

Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
por: Angelika M. Starzer, et al.
Publicado: (2022-04-01)

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial
por: Maximilian J. Mair, et al.
Publicado: (2023-02-01)

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
por: Matthias Preusser, et al.
Publicado: (2022-03-01)

New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
por: Anna S. Berghoff, et al.
Publicado: (2019-06-01)

Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up
por: Selma Tobudic, et al.
Publicado: (2022-07-01)

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations
por: Thomas Perkmann, et al.
Publicado: (2023-08-01)

The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination
por: Selma Tobudic, et al.
Publicado: (2023-02-01)

Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
por: Elisabeth Sophie Bergen, et al.
Publicado: (2021-04-01)

New developments in brain metastases
por: Anna S. Berghoff, et al.
Publicado: (2018-06-01)

Density and entropy of immune cells within the tumor microenvironment of primary tumors and matched brain metastases
por: Markus Kleinberger, et al.
Publicado: (2025-02-01)

Surveillance of respiratory syncytial virus infections in adults, Austria, 2017 to 2019
por: Lorenz Schubert, et al.
Publicado: (2021-04-01)

Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222
por: Thomas Perkmann, et al.
Publicado: (2021-09-01)

Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
por: Thomas Perkmann, et al.
Publicado: (2021-09-01)

Evaluation of the Septifast MGrade Test on Standard Care Wards--A Cohort Study.
por: Franz Ratzinger, et al.
Publicado: (2016-01-01)

Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases
por: Jagoda Pokryszka, et al.
Publicado: (2022-05-01)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
por: Melissa S Cline, et al.
Publicado: (2018-12-01)

SARS-CoV-2 infections in “less visible” hospital staff: The roles and safety of environmental services and allied health professionals
por: Sebastian Jensen, et al.
Publicado: (2023-09-01)

The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study
por: Thomas Perkmann, et al.
Publicado: (2022-02-01)

Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma
por: Matthias Preusser, et al.
Publicado: (2020-05-01)

Correction: Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania ‘Luigi Vanvitelli’
por: Matthias Preusser, et al.
Publicado: (2020-05-01)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Kara N. Maxwell, et al.
Publicado: (2017-08-01)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
por: Yuichiro Hatano, et al.
Publicado: (2020-03-01)

Epistatic relationships in the BRCA1-BRCA2 pathway.
por: Ralph Scully
Publicado: (2011-07-01)

Influence of Five Potential Anticancer Drugs on Wnt Pathway and Cell Survival in Human Biliary Tract Cancer Cells
por: Julia WACHTER, Daniel NEUREITER, Beate ALINGER, Martin PICHLER, Julia FUEREDER, Christian OBERDANNER, Pietro Di FAZIO, Matthias OCKER, Frieder BERR, Tobias KIESSLICH
Publicado: (2012-01-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
por: Pankaja Umarane, et al.
Publicado: (2023-03-01)

BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis
por: Qianyan Li, et al.
Publicado: (2021-04-01)

Comparison of the prevalence of SARS-CoV-2 nucleoprotein antibodies in healthcare workers and an unselected adult and paediatric all-comer patient population: insights from a longitudinal study of healthcare workers and concurrent serial cross-sectional studies of patients at an academic medical centre in Austria
por: Eva S Schernhammer, et al.
Publicado: (2023-01-01)

The Modern Approaches and Future Perspectives on Breast and Ovarian Cancer Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers: A Literature Overview
por: Sandra Sarnacka, et al.
Publicado: (2024-05-01)

Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer
por: Cornelia Englisch, et al.
Publicado: (2023-10-01)

Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency
por: Lisa Göschl, et al.
Publicado: (2022-09-01)

Human Borrelia miyamotoi Infection, Austria
por: Selma Tobudic, et al.
Publicado: (2020-09-01)

BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
por: Osman K., et al.
Publicado: (2022-12-01)

Roles of BRCA1 and BRCA2 in DNA replication and genome stability
por: Zimmer, J
Publicado: (2017)

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
por: M. M. Tsyganov, et al.
Publicado: (2020-07-01)

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
por: A. A. Kashintsev, et al.
Publicado: (2016-02-01)

Genetic Variation of The BRCA1 and BRCA2 Genes in Macedonian Patients
por: Plaseska-Karanfilska Dijana, et al.
Publicado: (2012-12-01)

Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
por: Ilirjana Bajrami, et al.
Publicado: (2021-11-01)

Diagnostic Screening Workflow for Mutations in the BRCA1 and BRCA2 Genes
por: Stella Lai, et al.
Publicado: (2015-01-01)

Prostate screening uptake in Australian <it>BRCA1 </it>and <it>BRCA2 </it>carriers
por: McKinley Joanne M, et al.
Publicado: (2007-09-01)